Exemestane Pregnancy and Breastfeeding Warnings
Exemestane is also known as: Aromasin
Exemestane Pregnancy Warnings
Exemestane has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of increased resorption, abortions, reduced number of live fetuses, prolonged gestation, abnormal or difficult labor, decreased fetal weight, and retarded ossification. There are no controlled data in human pregnancy. Exemestane is only indicated for use in postmenopausal women. If a pregnant women is exposed to exemestane, she should be made aware of the potential hazard to the fetus and the potential risk for loss of the pregnancy.
Exemestane Breastfeeding Warnings
There are no data on the excretion of exemestane into human milk. Animal tests have reported milk concentrations of exemestane and its metabolites were approximately equivalent to levels found in maternal plasma. Use of exemestane is not recommended in premenopausal women. Because many drugs are excreted into human milk, caution is recommended if a nursing mother becomes exposed to exemestane.
- exemestane Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.